Effect of Degarelix, a Gonadotropin-Releasing Hormone Receptor Antagonist for the Treatment of Prostate Cancer, on Cardiac Repolarisation in a Randomised, Placebo and Active Comparator Controlled Thorough QT/QTc Trial in Healthy Men

BACKGROUND AND OBJECTIVES: Degarelix is a gonadotropin-releasing hormone antagonist registered for the treatment of advanced hormone-dependent prostate cancer. Treatment causing androgen deprivation is associated with QT prolongation and this study investigated whether degarelix at supratherapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsson, Håkan, Petri, Niclas, Erichsen, Lars, Malmberg, Anders, Grundemar, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569649/
https://www.ncbi.nlm.nih.gov/pubmed/28660498
http://dx.doi.org/10.1007/s40261-017-0547-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569649/
https://www.ncbi.nlm.nih.gov/pubmed/28660498
http://dx.doi.org/10.1007/s40261-017-0547-7

Ejemplares similares